Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shugan Jieyu Capsule for generalized anxiety disorder
CTR20243469Phase 3Completed
- Sponsor
- Sichuan Jishengtang Pharmaceutical Co., Ltd.
- Start
- Sep 2024
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in generalized anxiety disorder (GAD) comparing Shugan Jieyu Capsule with Placebo (2 arms). Primary endpoint: Hamilton Anxiety Rating Scale total score. Started Sep 2024; status: completed.
02
Drugs
Shugan Jieyu
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on CTR20243469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243469.